Chinese study finds new CAR-T therapy may be safe, low-cost option

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Three patients with autoimmune diseases successfully treated with general purpose version of a therapy used to treat blood cancers.